Clinical Trial Update: Evaluation of Single and Repeat Doses of GSK729327 in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating single and repeat doses of the investigational compound GSK729327 in healthy volunteers, with schizophrenia listed as the condit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• GSK729327

Snippet

Sponsor: GlaxoSmithKline | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED